RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
New York City, the epicenter of COVID-19 pandemic, is likely to stay in lockdown into June, Mayor Bill de Blasio said at a press briefing.
Though some parts of New York state will be able to reopen starting May 15, that’s not likely to include NYC, said New York Governor Andrew Cuomo.
Hospital admissions and intensive-care admissions in the city have continued to decline, indicating progress is being made in slowing the spread of the virus. Still, the data on virus incidence shows that NYC is “clearly not ready yet” to reopen, de Blasio said.
That means the city’s pools and beaches will remain closed on Memorial Day, which is traditionally the first day they open.
Even in the lockdown, there may be a glimmer of hope for an uptick in economic activity as there are “early signs of turnaround in daily and weekly indicators for NYC subway usage,” according to Deutsche Bank.
Keep an eye on the data, though, to see if the increased subway usage then leads to an increase in virus cases.
Novavax (NASDAQ:NVAX) is up 26% after-hours on the heels of its Q1 report that included an announcement that nonprofit foundation Coalition for Epidemic Preparedness Innovations (CEPI) has agreed to invest up to an additional $384M to advance COVID-19 vaccine candidate NVX-CoV2373 – an increase that dwarfs its initial commitment of $4M. The company will use the funds to support clinical trials.
The Phase 1 portion of a Phase 1/2 study started this month. Preliminary safety and immunogenicity data should be available in July.
Results from animal studies showed high levels of spike protein-specific antibodies after one dose, which increased eight-fold with a second dose.
Novavax EPS beats by $0.13, beats on revenue
CapStone, a business incubator and investment group, announces $50M stake in Curaleaf (OTCPK:CURLF +4.8%)
CapStone was one of the largest investors in Curaleaf’s recent $300M senior loan facility closed in mid-January.
“Curaleaf has quickly become a leader in a $16B industry through thoughtful acquisitions, licensing, product development and expansion of retail dispensaries into new markets across the country,” said CapStone Holdings Chairman & Founder Keith J. Stone. “Curaleaf is well-positioned for continued growth and expansion across the U.S.”
Rockwell Medical (NASDAQ:RMTI): Q1 GAAP EPS of -$0.12 beats by $0.01.
Revenue of $15.86M (+1.9% Y/Y) beats by $0.31M.
Novavax (NASDAQ:NVAX): Q1 GAAP EPS of -$0.58 beats by $0.13.
Revenue of $3.38M (-15.1% Y/Y) beats by $1.45M.
Shares +11.7%.
